Nine-month clinical outcomes in patients with diabetes treated with polymer free sirolimus-eluting stents and dual-anti platelet therapy (DAPT) for 6 months versus DAPT for 12 months

被引：0

作者：

Krackhardt, Markus Florian ^{[1
]}

Waliszewski, Matt ^{[2
]}

Pons, Maxime ^{[3
]}

Verdun, Francois ^{[4
]}

Pansieri, Michel ^{[5
]}

Rios, Xabobe Flores ^{[6
]}

Lozano, Fernando ^{[7
]}

Boxberger, Michael ^{[8
]}

Kherad, Behrouz ^{[9
]}

机构：

[1] Charite, Augustenburger Pl, Berlin, Germany

[2] B Braun Vasc Syst, Berlin, Germany

[3] Clin Millenaire, Montpellier, France

[4] Hop Albert Schweitzer, Fdn Maison Diaconat, Cardiol, Colmar, France

[5] Ctr Hosp Avigon, Avignon, France

[6] Complejo Hosp Univ A Coruna, Coruna, Spain

[7] Univ Gen Hosp Ciudad Real, Ciudad Real, Spain

[8] B Braun, Berlin, Germany

[9] Charite, Berlin, Germany

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2017年 / 70卷 / 18期

关键词：

D O I：

10.1016/j.jacc.2017.09.966

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

TCT-731

引用

页码：B310 / B311

页数：2

共 41 条

[21] Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Sirolimus-Eluting Stent Randomized Substudy of the I-LOVE-IT 2 Trial
Han, Yaling
Xu, Bo
Xu, Kai
Guan, Changdong
Jing, Quanmin
Zheng, Qiangsun
Li, Xueqi
Zhao, Xianxian
Wang, Haichang
Zhao, Xuezhong
Li, Xiaoyan
Yu, Pengfei
Zang, Hongyun
Wang, Zhifang
Cao, Xuebin
Zhang, Jun
Pang, Wenyue
Li, Jing
Yang, Yuejin
Dangas, George D.
[J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (02) : 1 - 9
[22] Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in patients treated with percutaneous coronary intervention: the three-year outcomes of the SORT OUT X randomised clinical trial
Jakobsen, Lars
Christiansen, Evald H.
Freeman, Phillip
Kahlert, Johnny
Veien, Karsten
Maeng, Michael
Raungaard, Bent
Ellert, Julia
Villadsen, Anton B.
Kristensen, Steen D.
Christensen, Martin K.
Terkelsen, Christian J.
Aaroe, Jens
Thim, Troels
Lassen, Jens Flensted
Hougaard, Mikkel
Eftekhari, Ashkan
Jensen, Rebekka, V
Stottrup, Nicolaj B.
Rasmussen, Jeppe G.
Junker, Anders
Jensen, Svend E.
Hansen, Henrik S.
Jensen, Lisette O.
[J]. EUROINTERVENTION, 2023, 19 (08) : 676 - 683
[23] Outcomes of 6 Months Versus 12 Months Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Biolimus or Durable Polymer Zotarolimus-eluting Stents: OPTIMTCTAP A-C Study and Optical Coherence Tomography Sub-study
Kwon, Hyuck Moon
Lee, Byoung Kwon
Kang, Tae Soo
Yoon, Young Won
Min, Pil-Ki
Hong, Bum-Kee
Kim, Byeong-Keuk
Hong, Myeong-Ki
Jang, Yangsoo
Kang, Woong Chol
Kim, Byung Ok
Jeon, Dong Woon
Kim, Yong Hoon
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (17) : S1 - S1
[24] Risk of stent thrombosis with 6 vs. 12 months dual antiplatelet therapy after new generations drug-eluting stents implantation: final results of the multicenter prospective ESTROFA-DAPT study
De la Torre Hernandez, Jose M.
Dominguez, Juan F. Oteo
Hernandez, Felipe
Garcia Camarero, Tamara
Abdul-Jawad Altisent, Omar
Rivero-Crespo, Fernando
Cascon, Jose D.
Zavala, German
Gimeno, Federico
Arrebola-Moreno, Antonio L.
Andraka, Leire
Menchero, Antonio Gomez
Bosa, Francisco
Carrillo, Xavier
Sanchez-Recalde, Angel
Alfonso, Fernando
Perez de Prado, Armando
Palop, Ramon Lopez
Sanchis, Juan
Diarte de Miguel, Jose A.
De Lemos, Rocio
Munoz, Luz
Moreno, Antonio Ramirez
Tizon-Marcos, Helena
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B144 - B144
[25] Safety and Efficacy of 6-Month Versus 12-Month Dual Antiplatelet Therapy in Patients After Implantation of Multiple Biodegradable Polymer-Coated Sirolimus-Eluting Coronary Stents: Insight From the I-LOVE-IT 2 Trial
Qi, Jing
Li, Yi
Li, Jing
Jing, Quanmin
Xu, Kai
Gao, Chuanyu
Ma, Likun
Zhang, Zhi
Xu, Bo
Han, Yaling
[J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2017, 89 : 555 - 564
[26] Impact of Dual Anti-Platelet Therapy (DAPT) Duration on the Occurrence of Late (<1 Year) Stent Thrombosis (ST) in Unselected Patients Treated with Drug-Eluting Stents (DES) in the Real World Clinical Practice
Costa, Ricardo A.
Sousa, Amanda
Costa, J. Ribamar, Jr.
Moreira, Adriana
Maldonado, Galo
Cano, Manuel
Campos, Cantidio
Staico, Rodolfo
Abizaid, Alexandre
Mattos, Luiz A.
Feres, Fausto
Berwanger, Otavio
Sousa, J. Eduardo
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 175D - 175D
[27] Six Versus Twelve Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Biodegradable Polymer Sirolimus-Eluting Stents for Bifurcation Lesions: Insights From the I-LOVE-IT 2 Trial
Xu, Bo
Guan, Changdong
Xu, Kai
Jing, Quanmin
Yang, Yuejin
Han, Yaling
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B35 - B36
[28] A Meta-Analysis of Randomized Clinical Trials Comparing Shorter (Less or Equal Than 6 Months) and Longer (More or Equal Than 12 Months) Dual Anti-Platelet Therapy Following Drug-Eluting Coronary Stents
Yang, Jian
Fan, Zhi-Xing
Yang, Chao-Jun
Wang, Hui-Bo
[J]. IRANIAN RED CRESCENT MEDICAL JOURNAL, 2015, 17 (07)
[29] Real-World Use Of Ultrathin-Strut Biodegradable Polymer-Coated Sirolimus-Eluting Stents In Patients With Coronary Artery Disease: 6-Month Clinical Outcomes
Ajmera, Prakash
Pothineni, Ramesh
Chawla, Kamal Kumar
Mantravadi, Sai Sudhakar
Jariwala, Pankaj Vinod
Vijan, Vinod
Vijan, Vikrant
[J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2019, 15 : 439 - 447
[30] Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial
Harada, Yukinori
Colleran, Roisin
Kufner, Sebastian
Giacoppo, Daniele
Rheude, Tobias
Michel, Jonathan
Cassese, Salvatore
Ibrahim, Tareq
Laugwitz, Karl-Ludwig
Kastrati, Adnan
Byrne, Robert A.
[J]. CARDIOVASCULAR DIABETOLOGY, 2016, 15

← 1 2 3 4 5 →